Back

Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) trial: Primary Results

27 August 2017 (11:36 - 11:46)
Organised by:
Congress Presentation Part of: Hot Line: Late-Breaking Clinical Trials 1 Primary cardiovascular prevention: interventions and outcomes ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor John William Eikelboom

McMaster University, Hamilton (Canada)

14 More presentations in this session

Presentation thumbnail
Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure, the RACE 3 study
Professor I. Van Gelder (Groningen, NL)
Slides Video
Presentation thumbnail
Discussant review: Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure, the RACE 3 study.
Professor J. Brugada Terradellas (Barcelona, ES)
Slides Video
Presentation thumbnail
Panel discussion.
Presentation thumbnail
Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation: the CASTLE-AF trial
Professor N. Marrouche (New Orleans, US)
Slides Video
Presentation thumbnail
Discussant review: Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation: the CASTLE-AF trial
Professor M. Blomstrom-Lundqvist (Orebro, SE)
Slides Video

Access the full session

Session thumbnail
Hot Line: Late-Breaking Clinical Trials 1

The Event

Event poster

ESC Congress 2017

27 August 2017 11:36 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources